Today, GLP-1 receptor agonists and the newer dual GIP/GLP-1 receptor agonists have transformed obesity treatment by addressing the biological mechanisms that drive hunger and weight gain
Second, these medications have additional benefits such as weight loss and reduced cardiovascular risk, making them appealing therapeutic options
Additionally, a similar trend was observed in cell migration using the wound healing assay (Figure 7DE)
GLP-1 RAs: There are currently two GLP-1 receptor agonists approved for weight loss: liraglutide and semaglutide
The gut microbiome is fundamental to biological processes, including nutrient absorption, drug metabolism, energy homeostasis, immunity, and autoimmunity
What Are Peptides and Why Are They Important